A simple individual model for simulating weight gain dynamics in response to intake rate and daily behavior

It is often necessary to estimate the weight that an individual may be capable of gaining depending on its degree of activity. A simple individual-based model was developed for studying the dynamics of weight in terms of daily behavior and ingestion rate. It was based on the balance between the individual's energy intake and the cost of its daily activities. Costs depend on the weight of the individual and the photoperiod, as well as on the time spent on each activity. Different combinations of ingestion rate, individual's weight, photoperiod length, and time assigned to different activities were used for simulating the weight dynamics, taking the species Rhea americana as a study case. Estimations of energetic costs of the activities were obtained from specialized literature. Using different photoperiods and individual behaviors, the model yields field metabolic rate (FMR) values in agreement with those obtained from direct measurements for other omnivorous bird species.     

南京城市西部遗产廊道规划

南京城市西部历史时期是城市的重要边界,现在逐渐演变成老城与新区之间的核心地带,成为公共活动的重要地区,保护其自然、文化遗产和生态环境具有非常重要的意义。在对其现状调查分析的基础上,梳理遗产点的历史概况、现状及其分布情况,提出规划遗产廊道的意义,探讨规划的具体思路,为南京遗产保护提供了新的视角。     

城市生活垃圾循环利用系统物质代谢框架的构建

讨论了传统的物质流分析（MFA）方法用于城市生活垃圾代谢分析的适用性及不足之处,在此基础上结合城市生活垃圾的处理流程,对传统的MFA框架进行了改进,构建了适合城市生活垃圾代谢分析的框架,并对新框架的3个模块进行了详细的说明,建立了相应的评价指标体系并给出了应用实例。城市生活垃圾循环利用系统物质代谢分析框架能够清楚地描述生活垃圾进入经济系统后的具体流向和流量,为描述城市生活垃圾的代谢情况提供了定性及定量化的分析工具。     

曝气生物滤池中碳和氮代谢特性

用充填陶瓷滤料的曝气生物滤池研究碳和氮代谢特性.曝气生物滤池进水氨氮为52 mg/L左右、COD为100 mg/L左右和回流比为200%时,经过20多d的运行,出水氨氮小于0.05 mg/L、COD小于25 mg/L、亚硝态氮为4.7 mg/L和硝态氮为7.1 mg/L,COD去除率达75%,氨氮去除率达99.9%,总氮去除率达78%;过大和过小的回流比对曝气生物滤池的运行性能都是不利的.研究成果可以应用于一般城市污水以及含低COD、高氨氮工业废水的处理.     

新型人工快速渗滤系统处理村镇污水工艺参数优化

在巢湖双桥河建立了中试规模的人工快速渗滤系统(CRI),系统经过一个月左右启动期后挂膜成功。通过考察不同湿干比条件下CODMn、TP、TN和NH3-N的去除效果,确定系统湿干比为1 d∶2 d,水力负荷周期为3 d。TP、TN和NH3-N在1.0 m/d的水力负荷条件下能够达到最佳的处理效果,特别是TN;而CODMn在1.3 m/d取得最佳的去除效果。综合考虑脱氮除磷和有机污染物的去除,选取水力负荷为1.0 m/d可得到最佳的出水水质。综合4种污染物的去除特点,特别考虑到对TN去除的需要,同时兼顾工程成本,填料厚度确定为1.2～1.5 m之间为最佳。选取生物陶粒、钢渣、活性炭和天然沸石为渗滤介质,研究结果表明,从去除有机污染物和TP角度考虑,选取活性炭和钢渣可达到较好的去除效果,其中钢渣对TP去除效果更佳;而活性炭具有其他4种填料不可替代的脱氮效果。以上工艺组合形式的确定将为巢湖流域CRI系统的推广提供科学依据和数据支持。     

4-硝基酚的污泥减量化作用及对污泥性质的影响

为了有效减少活性污泥法中剩余污泥的产生,采用解偶联剂4-硝基酚对活性污泥工艺中的剩余污泥进行减量化研究。研究了4-硝基酚对污泥的增长速率、基质去除率以及污泥性质的影响。结果表明:4-硝基酚对污泥的减量化作用明显,在对微生物解偶联的过程中并不影响微生物对基质的利用能力;对出水中的氨氮影响甚小,总氮、总磷浓度有轻微的升高。4-硝基酚能够刺激污泥中微生物的活性,比耗氧速率增加,促进能量解偶联,从而降低污泥产率。4-硝基酚使污泥中微生物的群落结构发生了轻微的变化,但对污泥的松散程度和絮凝沉降性能影响甚小。     

污泥停留时间对单级好氧生物除磷的影响

以丙酸钠为单一碳源,设置4组不同污泥停留时间(SRT)的SBR(R1:SRT=9 d;R2:SRT=12 d;R3:SRT=18 d;R4:SRT=24 d),考察SRT对单级好氧生物除磷的影响。实验结果表明,当SRT分别为9、12、18和24 d时除磷效率分别为34.2%、85.0%、93.3%和76.7%,单位VSS除磷量分别为1.97、4.62、4.70和3.59 mg-P/g-VSS,SVI分别稳定在89、93、98和123 mL/g左右。随着SRT增大,系统除磷效率及单位VSS除磷量先升高后下降,并在SRT=18 d时达到最大值,而污泥沉降性能逐渐变差。分析各组反应器中内聚物的变化表明,R1中的微生物在外源基质消耗阶段利用糖原质的分解合成多β羟基烷酸盐(PHA),但PHA消耗阶段没有磷酸盐的大量吸收,表现出聚糖菌的代谢方式;R2、R3和R4中的微生物在外源基质消耗阶段通过TCA循环合成PHA,在PHA消耗阶段大量合成聚磷,表现出聚磷菌的代谢方式。     

Prenatal diagnosis of inherited metabolic disorders by quantitation of characteristic metabolites in amniotic fluid: Facts and future

An attempt is made to summarize as completely as possible what is known about the prenatal diagnosis of amino– and organic acidurias by direct measurement of characteristic metabolites in amniotic fluid, and to indicate which disorders can potentially be diagnosed prenatally by direct quantitation of metabolites. Furthermore, the disorders are mentioned in which the prenatal diagnosis was proven to be unsuccessful by this approach. The prenatal diagnoses of a case of propionic acidemia and a case of tyrosinemia type I in the 11th and 12th week of gestational age, respectively, are reported and the prospects of performing amniocentesis in the first trimester for prenatal diagnosis are discussed.     

可持续发展模式下环境--经济协调发展程度定量评价

环境与经济的协调发展是实现可持续发展的重要途径。利用系统学原理和数理统计方法提出可持续发展模式下的环境与经济协调定量评价方法，对环境——经济协调度定量评估的步骤、方法包括数学模型的选择、建构，协调发展度指数的确定、推导和测算以及评价原则进行了具体的阐述。     

First-trimester biochemical and molecular diagnoses using chorionic villi: High accuracy in the U.S. collaborative study

The accuracy of biochemical and molecular prenatal diagnoses using chorionic villi as the fetal source was assessed by seven centres participating in the NICHD collaborative study on the safety and accuracy of chorionic villus sampling (CVS) and amniocentesis. Of 601 pregnancies studied, biochemical methods were used to determine the diagnosis in 283 fetuses at risk for 35 different metabolic disorders. Fifteen different lysosomal storage diseases accounted for 81 per cent of the biochemical prenatal diagnoses performed, with 57 per cent of these pregnancies at risk for Tay-Sachs disease. No errors were made in the biochemical diagnoses that predicted affected or unaffected fetuses. However, the diagnoses of certain disorders (e.g., mucopolysacchariodosis type IH, metachromatic leukodystrophy, and Krabbe disease) occasionally required confirmatory studies in cultured amniocytes because the enzyme results were inconclusive in direct and/or cultured villi or due to the presence of a pseudodeficiency allele. Of these, only the diagnosis of a fetus at risk for Krabbe disease remained inconclusive after special studies to discriminate between mutant and pseudodeficiency alleles. Recombinant DNA techniques were used to predict the diagnosis of 318 fetuses at risk for 16 different disorders in which the defective disease gene could be detected either directly or by linkage analysis to a nearby polymorphic marker. Of these, 32 per cent were for haemoglobinopathies, 25 per cent for cystic fibrosis, 24 per cent for Duchenne or Becker muscular dystrophy, and 7 per cent for haemophilias. Pregnancies at risk for known disorders with specific molecular lesions (e.g., sickle cell disease) were accurately diagnosed in direct and/or cultured villi. Diagnoses requiring analyses with closely linked polymorphic markers were occasionally uninformative or inconclusive. Maternal contamination was not reported in any biochemical or molecular-based diagnosis. These studies document the high accuracy and rapidity of both biochemical and mutation-specific prenatal diagnoses with direct and cultured chorionic villi.